CryoPort Inc (CYRX) Expected to Post Earnings of -$0.07 Per Share

Brokerages expect that CryoPort Inc (NASDAQ:CYRX) will report earnings of ($0.07) per share for the current quarter, according to Zacks. Three analysts have provided estimates for CryoPort’s earnings, with the lowest EPS estimate coming in at ($0.08) and the highest estimate coming in at ($0.04). CryoPort reported earnings per share of ($0.12) during the same quarter last year, which would suggest a positive year over year growth rate of 41.7%. The firm is scheduled to announce its next earnings results on Monday, March 12th.

According to Zacks, analysts expect that CryoPort will report full-year earnings of ($0.32) per share for the current fiscal year, with EPS estimates ranging from ($0.34) to ($0.29). For the next year, analysts expect that the business will post earnings of ($0.23) per share, with EPS estimates ranging from ($0.26) to ($0.18). Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow CryoPort.

CryoPort (NASDAQ:CYRX) last issued its earnings results on Wednesday, November 1st. The consumer goods maker reported ($0.08) EPS for the quarter, hitting analysts’ consensus estimates of ($0.08). CryoPort had a negative net margin of 91.28% and a negative return on equity of 46.99%.

A number of equities analysts recently commented on CYRX shares. Janney Montgomery Scott boosted their target price on shares of CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a research note on Tuesday, October 3rd. Roth Capital started coverage on shares of CryoPort in a research note on Thursday, November 30th. They set a “buy” rating and a $12.50 target price for the company. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $33.50.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Northern Trust Corp lifted its position in CryoPort by 105.0% in the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock valued at $109,000 after acquiring an additional 11,358 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new stake in CryoPort in the third quarter valued at $118,000. Bank of Montreal Can purchased a new stake in CryoPort in the fourth quarter valued at $142,000. Wolverine Trading LLC purchased a new stake in CryoPort in the third quarter valued at $230,000. Finally, Granite Investment Partners LLC purchased a new stake in CryoPort in the third quarter valued at $535,000. 18.10% of the stock is owned by hedge funds and other institutional investors.

CryoPort (NASDAQ CYRX) opened at $8.36 on Friday. The company has a market cap of $214.54, a price-to-earnings ratio of -16.39 and a beta of 0.99. CryoPort has a 12 month low of $1.96 and a 12 month high of $10.40.

WARNING: “CryoPort Inc (CYRX) Expected to Post Earnings of -$0.07 Per Share” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright legislation. The original version of this piece can be read at

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for CryoPort (NASDAQ:CYRX)

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with's FREE daily email newsletter.

Leave a Reply